Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
53,311,882
-
Total 13F shares
-
3,246,429
-
Share change
-
+106,326
-
Total reported value
-
$23,591,651
-
Price per share
-
$7.27
-
Number of holders
-
36
-
Value change
-
+$953,511
-
Number of buys
-
20
-
Number of sells
-
21
Institutional Holders of Aktis Oncology, Inc. - Common Stock, $0.0001 par value per share (AKTSQ) as of Q2 2018
As of 30 Jun 2018,
Aktis Oncology, Inc. - Common Stock, $0.0001 par value per share (AKTSQ) was held by
36 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,246,429 shares.
The largest 10 holders included
Herald Investment Management Ltd, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, Precept Management LLC, Financial Advocates Investment Management, SALEM INVESTMENT COUNSELORS INC, D.A. DAVIDSON & CO., ESSEX INVESTMENT MANAGEMENT CO LLC, UBS Group AG, and THOMPSON DAVIS & CO., INC..
This page lists
36
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.